Chemed Corporation reported its third quarter 2020 operating results, which showed improvement from the second quarter due to operational changes made by its hospice and Roto-Rooter segments. VITAS Healthcare Corporation's admissions increased by 4.7% in the third quarter, with July, August, and September admissions expanding by 4.3%, 5.9%, and 4%, respectively. The average daily census declined by 2-tenths of 1 percentage point in the quarter, but is expected to normalize when nursing homes and assisted-living facilities return to their pre-COVID occupancy levels. Roto-Rooter services demand showed significant improvement in the third quarter, with unit-for-unit commercial revenue increasing by 26.8% when compared to the second quarter. The full year 2020 revenue growth for Roto-Rooter is forecasted to be 12.5% to 13%, with a sequential revenue growth of 2.7% from the third quarter to the fourth quarter. Chemed's full year 2020 adjusted earnings per diluted share, excluding non-cash expense for stock options, tax benefits for stock options, costs related to litigation and other discrete items, is estimated to be in the range of $18 to $18.15. The company's entire team will continue to prioritize the safety of its team members and patients, utilizing resources and testing supplies to comply with federal, state, and local requirements to safely access healthcare facilities in their markets.